The $2 Trillion Valuation Debate Skips What Anthropic Knows 
Pharmacore secures funding to improve medication regimen reviews in long-term care Genmab and argenx Enter Partnership to Advance Antibody Therapies in Immunology and Oncology
Media Release COPENHAGEN, Denmark; April 17, 2023 Genmab and argenx have entered a multiyear collaboration bringing together capabilities…
Smart Immune receives $5 million investment to further its thymus-empowered ProTcell therapy platform
Smart Immune receives $5 million investment to further its thymus-empowered ProTcell therapy platform The new…
PlayMining Web3 Gaming Platform Announces Game Launch and NFT Presale for “Lost Archive +”
PlayMining Game ‘Lost Archive +’ Launches in May, NFT Presale in late April ‘Lost Archive…
Synergy House Berhad Obtains Approval for ACE Market Listing, Engages Kenanga IB as Underwriter
KUALA LUMPUR, Apr 17, 2023 – (ACN Newswire) – SYNERGY HOUSE BERHAD, a cross-border e-commerce…
Content Remains King in the Future of Video in India
MUMBAI, INDIA, Apr 17, 2023 – (ACN Newswire) – The Asia Video Industry Association’s (AVIA)…
OPEX Partners with Advanced Robotics in Hungary to Provide Innovative Warehouse Automation Solutions
Advanced Robotics Becomes the First OPEX Integrator to Implement OPEX Perfect Pick Goods-to-Person System in…
Singapore Continues To Lead the Way in Asia in Judicial Blocking of Illegal Streaming Sites, but More Can Be Done
Singapore, Apr 17, 2023 – (ACN Newswire) – The Asia Video Industry Association’s Coalition Against…
Inflight Entertainment Features Indonesia as a Partner Country for Hannover Messe 2023
JAKARTA, Apr 17, 2023 – (ACN Newswire) – Within a few days, Hannover Messe 2023,…
SNBL to Acquire Satsuma Pharmaceuticals
Transaction delivers immediate value and liquidity to Satsuma stockholders SNBL to acquire all outstanding shares…
Over half of consumers have been a victim of financial crime according to latest report from Feedzai
Feedzai’s new report reveals a lack of awareness of scams is putting many consumers at…
Vaxcyte to Host Webcast and Conference Call to Discuss Results from Phase 2 Study of its 24-Valent Pneumococcal Conjugate Vaccine Candidate in Adults Aged 65 and Older and Full Six-Month Safety Data from Both Adult Phase 2 Studies
SAN CARLOS, Calif., April 16, 2023 (GLOBE NEWSWIRE) — Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage…
Frontier Medicines Presents New Preclinical Data on its Development Candidate, FMC-376, a Dual KRASG12C Inhibitor, at the 2023 AACR Annual Meeting
-FMC-376 is a highly selective, direct dual inhibitor designed to rapidly and completely block both…
Blackmagic Design Announces DaVinci Resolve 18.5
Major update adds new AI based tools, new Resolve FX, text based editing, speech to…
Affimed Presents Final Data Demonstrating Safety and Efficacy of AFM13 Phase 2 REDIRECT Study in Patients with Heavily Pretreated Relapsed or Refractory Peripheral T Cell Lymphoma at the American Association for Cancer Research Annual Meeting 2023
AFM13 demonstrated robust activity on the primary end point with an objective response rate (ORR)…
Blackmagic Design Announces New DeckLink IP HD
New family of capture and play back PCIe cards for 2110 IP broadcast systems. LAS…
Roche’s Tecentriq plus Avastin reduced the risk of cancer returning in people with certain types of adjuvant liver cancer in a Phase III study
In the first-ever positive Phase III trial in the adjuvant hepatocellular carcinoma (HCC) setting, Tecentriq…
Raising the Quality and Innovation Bars: MediaKind Introduces ‘More’ Technology and Partnerships at NAB Show 2023
FRISCO, Texas–(BUSINESS WIRE)–Join MediaKind at the NAB Show from April 16th to the 19th at…
Blackmagic Design Announces New ATEM Television Studio 4K8
New 12G-SDI live production switcher with built in broadcast panel and support for standards up…
Evergent Announces its Flagship Evergent Monetization Platform will Now Be Available On Google Cloud Marketplace
Organizations can now access this flexible customer management and monetization platform running on Google Cloud…
Merck Strengthens Immunology Pipeline with Acquisition of Prometheus Biosciences, Inc.
PRA023 is a novel, late-stage candidate for ulcerative colitis and Crohn’s disease and other autoimmune…